SonoSite this month won 510(k) clearance from the FDA to market its X-Porte ultrasound kiosk in the U.S., and the device maker’s planning to start shipping the device immediately.
The Bothell, Wash.-based medical device company said called the kiosk is an "important milestone” in providing access to point-of-care ultrasound visualization. The kiosk uses SonoSite’s proprietary Extreme Definition Imaging, which reduces imaging clutter to provide a higher resolution picture.
The X-Porte is the 1st device of its kind to and is already available in parts of Europe and Asia, according to the press release.
“This is a major accomplishment for SonoSite and a defining moment in the next phase of our innovation strategy," president & CEO Kevin M. Goodwin said in prepared remarks. "Working side-by-side with hundreds of clinicians from the frontlines of medicine worldwide, we combined their many insights with the most innovative consumer technologies available today. Then, we blended in our own inspiration from key engineers at our company, creating a remarkable new tool built from the ground up."
Fujifilm Holdings (TSE:4901) bought out SonoSite in April 2012, for around $995 million. SonoSite maintained its management team and runs as a wholly-owned subsidiary.